Ibuflamar

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ibuflamar

Property Description
Active Ingredient Ibuprofen
Form Tablet, Film-coated tablet, Oral suspension
Pharmacological Class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common Action Analgesic, Anti-inflammatory, Antipyretic
Origin Synthetic (Propionic acid derivative)

What Type of Medicine is Ibuflamar?

Ibuflamar is a specific medicinal preparation whose therapeutic action is derived from its main active substance, Ibuprofen. Scientifically, the drug is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and an associated Non-Opioid Analgesic. This compound is synthetic, belonging chemically to the propionic acid derivative group. As an NSAID, Ibuprofen is an anti-inflammatory agent. This confirms that the medication is designed to fight inflammation, not just mask the pain.

Composition and Available Forms (Tablets and Suspensions)

The core composition of Ibuflamar is Ibuprofen, though the brand may be marketed as a single-ingredient product or as a combination product, frequently featuring the addition of Paracetamol (Acetaminophen) to enhance the overall pain-relieving effect. For oral administration, the product is commonly supplied in multiple official dosage forms, including the standard tablet, the film-coated tablet, and the oral suspension liquid. The oral suspension form is available for the pediatric patient group to ensure ease of consumption, while tablets cater to adult needs.

What is the General Therapeutic Purpose of Ibuflamar?

The general therapeutic purpose of Ibuflamar is to provide combined symptomatic relief through its characteristic triple physiological action. This action involves achieving an analgesic effect (relieving pain), an anti-inflammatory effect (reducing swelling), and an antipyretic effect (lowering elevated body temperature). Its function is accomplished via the inhibition of prostaglandin synthesis. This mechanism manages the three main symptoms of discomfort: pain, inflammation, and fever. Ibuflamar thus functions as a comprehensive symptomatic tool designed to mitigate discomfort associated with acute and chronic physiological responses.

Regulatory References

  1. NIH: MedlinePlus - Ibuprofen

What side effects are possible with Ibuflamar?

Possible Side Effects and Safety Information for Ibuflamar

Ibuflamar (a fixed-dose combination of Ibuprofen and Paracetamol) is associated with adverse reactions that are officially classified by frequency and by the body system affected (System-Organ Class).

Frequency-Classified Adverse Reactions

Side effects are categorized by how often they occur, based on regulatory data (Very Common, Common, Uncommon, Rare, Very Rare, Not Known).

Classification Examples of Documented Reactions
Common Nausea, vomiting, dyspepsia, headache, dizziness.
Uncommon Skin rash, hypersensitivity reactions.
Rare/Very Rare Severe skin reactions, severe liver injury, blood disorders (e.g., anemia).

Serious Adverse Reactions and Safety Constraints

Regulatory documents include warnings about rare but serious risks associated with the components of Ibuflamar:

  • Gastrointestinal Risk: Increased risk of serious GI events, including bleeding, ulceration, and perforation, which can be fatal. This risk may increase with higher doses and longer duration of use.
  • Cardiovascular Risk: Increased risk of serious cardiovascular thrombotic events, such as Myocardial Infarction and Stroke. The medicine is contraindicated following Coronary Artery Bypass Graft (CABG) surgery.
  • Hepatotoxicity: Risk of severe liver injury (hepatotoxicity), especially with the Paracetamol component.
  • Severe Skin Reactions (SCARs): Documented risk of severe cutaneous adverse reactions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).

Population-Specific Safety Considerations

  • Pregnancy: The NSAID component (Ibuprofen) is contraindicated starting at 30 weeks of gestation due to potential fetal harm.
  • Elderly Patients: Older individuals are at a significantly higher risk for serious gastrointestinal and renal adverse events.
  • Impairment: Caution and official monitoring are required for patients with pre-existing severe renal or hepatic impairment. The medicine is contraindicated in severe heart, liver, or kidney failure.

The official safety profile mandates the use of the lowest effective dose for the shortest duration necessary to minimize the risk of serious adverse reactions.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documents for Ibuflamar (Ibuprofen) detail the potential signs and necessary emergency actions required in the event of an overdose.

Overdose exposure may result in documented clinical manifestations that frequently include gastrointestinal distress, such as nausea, vomiting, and abdominal pain. Central Nervous System (CNS) effects are also common, presenting as dizziness, lethargy, somnolence, and confusion. Sensory symptoms like tinnitus (ringing in the ears) have also been reported.

Officially Documented Severe Outcomes

System Affected Severe Manifestation
CNS Seizures, Coma
Cardiovascular/Renal Hypotension (low blood pressure), Acute Renal Failure
Metabolic Metabolic Acidosis

Urgent Medical Response Required

Regulatory guidelines mandate that immediate medical attention must be sought for any suspected overdose. Contact the local Poison Control Center or emergency services right away.

It is officially documented that no specific antidote is known for Ibuprofen overdose. Management is therefore limited to symptomatic and supportive treatment. This includes interventions such as gastric decontamination with activated charcoal for recent, large ingestions. Hospital monitoring is required, with observation periods extending to at least 4 to 8 hours to monitor vital signs and laboratory function due to the risk of severe complications.

Therapeutic Uses of Ibuflamar

The therapeutic role of Ibuflamar is applied across domains where additional symptomatic support is needed in conditions marked by acute or recurrent discomfort, inflammation, and fever. It is relevant in clinical settings that involve acute or unstable symptom patterns.

Ibuflamar is commonly used for managing symptoms related to both systemic imbalance and local inflammation. The medication is considered relevant for easing symptomatic discomfort associated with the common cold, flu, headaches, toothaches, backaches, menstrual cramps, sprains, strains, osteoarthritis, and rheumatoid arthritis. It is relevant for managing symptoms that interfere with daily comfort.

“It supports patients during episodes of heightened discomfort and contributes to easing the overall symptom load.”

Quick Fact: Focus on Symptomatic Discomfort

Ibuflamar is relevant for easing symptoms related to heightened physiological activity. It helps manage symptom clusters that may become intense or disruptive, including physical pain, elevated fever, and signs of inflammation and swelling. The medication is applied in situations requiring short-term symptomatic assistance across these therapeutic domains.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Ibuflamar?

Ibuflamar (a fictionalized ibuprofen-based product) is primarily indicated for use in adults and children over 6 months of age for the temporary relief of pain and fever. For children, dosage is strictly based on weight, not age.


Contraindications: When Ibuflamar Must Be Avoided

Ibuflamar, like other nonsteroidal anti-inflammatory drugs (NSAIDs), is contraindicated in several specific populations. It should not be used if you have:

  • A known allergy or hypersensitivity reaction (e.g., asthma, hives, or severe rash) to ibuprofen, aspirin, or other NSAIDs.
  • Active or recurrent stomach ulcers or bleeding in the stomach/intestines.
  • Severe heart failure (NYHA Class IV), severe kidney failure, or severe liver failure.
  • The third trimester of pregnancy (after 28 weeks).
  • Are scheduled for or have recently had coronary artery bypass graft (CABG) surgery.

Consult a healthcare professional before use if you have a history of gastrointestinal bleeding, high blood pressure, heart disease, asthma, or are taking blood thinners or other medications, especially during the first and second trimesters of pregnancy.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Ibuflamar's active ingredient, Ibuprofen (an NSAID), has documented interactions that require specific restrictions or careful co-administration, as stated in regulatory prescribing information.

Contraindications and Restrictions

Co-administration with other Nonsteroidal Anti-inflammatory Drugs (NSAIDs), including high-dose Aspirin, should generally be avoided due to a significantly increased risk of serious gastrointestinal adverse events. Furthermore, regulatory documents state that use is contraindicated for treating peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.

Pharmacodynamic and Exposure Interactions

Interactions are categorized by those that increase risk and those that alter drug concentrations:

  • Risk of Bleeding: Concomitant use with Anticoagulants (e.g., Warfarin), Antiplatelet Agents, SSRIs, or Corticosteroids enhances the risk of gastrointestinal bleeding and ulceration.
  • Altered Efficacy: Ibuprofen may diminish the antihypertensive effects of medicines like ACE Inhibitors and Diuretics, and may also interfere with the antiplatelet effect of low-dose Aspirin.
  • Increased Exposure: Ibuprofen reduces the renal clearance of drugs such as Lithium and Methotrexate, which can lead to increased plasma concentrations and potential toxicity.

Administration Requirements

If co-administration with immediate-release low-dose Aspirin is necessary, a time separation is required: Ibuprofen must be taken at least 8 hours before or 30 minutes after the aspirin dose. Regulatory documents note that alcohol (three or more drinks per day) increases the risk of gastrointestinal bleeding.

Mechanism of Action

Primary Action: Enzyme Inhibition and Mediator Suppression

Ibuflamar's primary mechanism involves the targeted inhibition of the Cyclooxygenase ( COX) enzyme, a key enzymatic step in the creation of prostaglandins and other eicosanoid mediators. This interaction limits the initial molecular sequence within the eicosanoid cascade.

Modulating Local Physiological Signaling

By limiting the production of these signaling molecules, the drug directly alters local pathway activity that may escalate under certain physiological conditions. This mechanistic dampening of excessive mediator release leads to a reduction in the magnitude of signaling within affected pathways.

Downstream Effect on Core Mechanisms

The drug engages mechanisms that influence the early molecular steps within defined pathways, modifying the signals that shape the final physiological outcomes. This focused action results in reduced mediator activity within biological systems, which influences the magnitude of downstream physiological adjustments.

Dosage and Administration Information

How Ibuflamar is Used: Official Administration Guidelines

Ibuflamar, containing the active substance Ibuprofen, is administered according to specific principles to ensure proper use. The overarching principle for all use is to apply the lowest effective dosage for the shortest duration consistent with the patient’s therapeutic goals.

The medicine is officially approved for administration via the Oral route (tablet, suspension), Intravenous (IV) injection in clinical settings, and Topical application.

Dosage and Frequency

Administration Pattern Adult Dosing (Single/Maximum Daily) Frequency and Interval
Oral (Acute/OTC) 200 mg to 400 mg / up to 1200 mg Every 4 to 6 hours; minimum 4-hour interval
Oral (Prescription) 400 mg to 800 mg / up to 3200 mg Divided doses, three to four times daily
Pediatric (Oral) Weight-based: 5 mg/kg to 10 mg/kg Every 6 to 8 hours; maximum 40 mg/kg/day

Administration Specifics

Oral tablets must be swallowed whole with fluid and should not be chewed or crushed to prevent local irritation. It is often recommended to take the dose with food or milk to reduce the potential for stomach upset.

For children, the oral suspension must be shaken well before the required dose is measured. Intravenous administration requires dilution of the solution and is only carried out under clinical supervision, often infused over a set duration.

Recent Clinical Evidence

Research evidence / Overview of Studies for Ibuflamar

This section provides a transparent summary of the clinical research conducted on the medicine, describing the types of studies that exist and what their findings indicate, without offering any medical advice or recommendations.


Evidence for Acute Symptomatic Pain Relief

Research was studied for its use during acute or disruptive episodes of physical discomfort, such as sudden headaches, musculoskeletal strains, or pain following minor procedures. The foundational evidence is derived from numerous Randomized Controlled Trials (RCTs), which have been compiled and analyzed in Systematic Reviews and Meta-Analyses.

These studies were primarily applied in trials assessing short-term or episodic symptom patterns. The research base provides context on research exploring short-term symptom changes, and research does not determine whether an individual will respond similarly during prolonged use.


Evidence for Fever Reduction (Antipyresis)

The medicine was studied for its role in research examining temporary physiological imbalance (fever), often associated with conditions involving periods of heightened symptoms. The evidence relies on RCTs and Comparative Meta-Analyses, with focus on how temperature measures were recorded in both adult and pediatric populations.

The studies research examined outcomes linked to physiological strain or stress. When compared to other common fever-reducing agents, findings were mixed regarding the measured variability in the rate of temperature change. Consequently, some comparative evidence is lacking in showing substantial differences.


Evidence for Chronic Inflammatory Conditions

The medicine was evaluated in settings involving chronic conditions marked by functional limitations, such as Osteoarthritis and Rheumatoid Arthritis. This evidence comes from longer RCTs and Long-term Observational Studies. Study reports indicate the patterns observed were associated with the administered dose, and certainty remains low regarding sustained, long-term functional changes.


Evidence Gaps and Areas of Uncertainty

Scientific reviews have described the general structure of the evidence for the medicine, yet they have also identified specific gaps. The overall evidence quality varies across studies. There is limited information for long-term outcomes regarding functional status, and the results apply only to the populations studied.

Key Studies & References

  1. Ibuprofen: MedlinePlus Drug Information (Authoritative Patient Guidance)

Frequently Asked Questions (FAQ)

Common questions about Ibuflamar (FAQ)


Q: Is Ibuflamar the same type of medication as [Common OTC Drug Name]?

Ibuflamar is a brand name for a product whose active substance is Ibuprofen. According to official classification, Ibuprofen is a Nonsteroidal Anti-inflammatory Drug (NSAID).

This means it belongs to the same class of medicines as many common over-the-counter pain relievers.


Q: Is it true that Ibuflamar can affect blood pressure?

Official warnings note that NSAIDs like Ibuflamar may diminish the expected blood pressure-lowering effects of certain medicines, such as ACE inhibitors and diuretics.

It is also noted in official documents that the drug may cause a small increase in blood pressure in individuals who already have hypertension.


Q: What is the difference between Ibuflamar and other similar anti-inflammatory drugs?

Ibuflamar's active ingredient is Ibuprofen, which is classified as a propionic acid derivative and an NSAID. All NSAIDs share the same general mechanism of action by targeting the Cyclooxygenase (COX) enzyme.

The primary difference between various NSAIDs often relates to their duration of action and specific chemical structure.


Q: Can older adults typically use Ibuflamar safely?

Regulatory documents indicate that older individuals face a significantly higher risk for serious gastrointestinal, cardiovascular, and kidney-related side effects.

To help minimize this risk, the regulatory philosophy emphasizes using the lowest effective dose for the shortest duration consistent with therapeutic goals.


Q: Can Ibuflamar be taken with common pain relievers like Tylenol (acetaminophen)?

Ibuflamar is sometimes sold as a combination product that already includes Acetaminophen (Paracetamol). In its single-ingredient form, it is typically compatible with Acetaminophen because the drugs act via different mechanisms.

However, professional guidance should always be sought before combining medications.


Q: Is it normal to feel dizzy or drowsy after taking Ibuflamar?

Official adverse reaction data lists dizziness as a common side effect of the medicine. Drowsiness is not explicitly listed as a common reaction in all regulatory documents, though its effects on the central nervous system have been noted.


Q: Can someone with asthma typically use Ibuflamar?

The medicine is contraindicated (should be avoided) if there is a known allergy or hypersensitivity reaction to NSAIDs. This includes cases where NSAIDs can trigger or worsen asthma symptoms, hives, or a severe rash.


Q: What is the meaning of 'Contraindications' in the context of Ibuflamar?

A contraindication is a regulatory term for a condition or factor that prevents a medical treatment from being used due to the harm it would likely cause the patient. These are serious restrictions noted in the product label.

For Ibuflamar, contraindications include conditions like severe heart failure, active stomach ulcers, and use during the third trimester of pregnancy.


Q: What are the potential drug interactions with common anti-depressants?

Ibuflamar has a documented interaction with selective serotonin reuptake inhibitors (SSRIs), a common class of anti-depressants.

Co-administration of Ibuflamar with SSRIs is noted to enhance the risk of serious gastrointestinal bleeding and ulceration, as documented in regulatory sources.


Q: How quickly should I expect Ibuflamar to start working?

Studies and official information indicate that for pain relief, the medicine usually begins to work within 20 to 30 minutes after consumption.

The maximum level of pain relief is typically achieved within one to two hours.


Q: Is Ibuflamar considered a controlled substance?

No, according to major drug regulatory schedules, Ibuflamar (Ibuprofen) is not classified as a controlled substance, drug of abuse, or narcotic. It is categorized as a non-opioid pain reliever.


Q: Are there any specific foods I should avoid while using Ibuflamar?

The drug label strongly emphasizes avoiding co-administration with alcohol (three or more drinks per day) due to a significantly increased risk of gastrointestinal bleeding.

No specific food interactions are typically listed in regulatory documents.


Q: What is the maximum amount of time Ibuflamar is intended to be used?

For over-the-counter use in adults, regulatory guidelines generally recommend that the medicine should not be taken for longer than 10 days for pain or fever.

Use for periods longer than this typically requires oversight from a healthcare professional.


Q: Is there evidence that Ibuflamar is safe to use while breastfeeding?

Official health data indicates that Ibuflamar's active ingredient, Ibuprofen, is often deemed acceptable for pain relief in nursing mothers.

Only very low levels of the drug are found in breast milk, and it is known to have a short half-life.


Q: What happens if I miss a dose of Ibuflamar?

If the medicine is taken only as needed (P.R.N.), the general guidance is to skip the missed dose. If on a scheduled regimen, guidance usually involves specific instructions on whether or not to take the missed dose, but regulatory information universally warns against taking a double dose.


Q: Does Ibuflamar affect sleep patterns?

Some nonsteroidal anti-inflammatory drugs (NSAIDs), including Ibuprofen, have been connected in studies to potential, minor disruption of normal sleep patterns.

This may include increasing the number of awakenings or slightly delaying the onset of deeper sleep stages.


Q: Are there any known drug-herb interactions with Ibuflamar?

Specific herb interactions are not always listed on standard regulatory documents. However, regulatory guidance emphasizes the importance of sharing information regarding all supplements and herbs with a healthcare provider, especially those that may affect blood clotting or gastrointestinal health.


Q: How long does Ibuflamar typically stay in the body after the last use?

Pharmacokinetics data shows that Ibuprofen has a half-life of about two hours.

It generally takes approximately 10 hours for the body to completely eliminate trace amounts of the medication from the system after the last dose.


Q: Is the medication meant to be taken regularly or only when needed?

For acute pain and fever, the medicine is typically taken only as needed (P.R.N.).

For severe or continuing conditions, such as certain types of arthritis, a doctor may order it to be taken regularly to maintain a sustained effect in the body.


Q: What is the general duration of effect for a single dose of Ibuflamar?

Patient information leaflets indicate that a single dose of Ibuflamar typically provides effective pain relief for approximately four to six hours.

This duration informs the necessary interval between doses.


Q: Is there a risk of dependency or addiction associated with Ibuflamar?

Ibuflamar (Ibuprofen) is a non-opioid pain reliever and is not associated with physical dependence or addiction in the way controlled substances are.

The need for strict adherence to authorized use instructions applies to all medications to prevent health consequences.


Q: Does Ibuflamar have any known effects on fertility?

Regulatory documents mention that some nonsteroidal anti-inflammatory drugs (NSAIDs) may be associated with the reversible inhibition of ovulation.

This effect could potentially impair female fertility, but it is usually temporary and resolves upon discontinuation of the medicine.


Q: Can Ibuflamar interact with supplements like fish oil or multivitamins?

Regulatory documents note the need for caution when combining Ibuflamar with supplements that may affect blood clotting.

This is due to the increased risk of bleeding already associated with the NSAID component, and includes high-dose fish oil or certain herbal supplements.

How should Ibuflamar be stored and disposed of?

How to Store and Dispose of Ibuflamar?

Storing and disposing of Ibuflamar must follow the official guidelines to maintain product quality and safety.

Storage Requirement Official Guideline
Temperature Store below the stated maximum temperature (e.g., 25 C or 30 C), generally at room temperature. Avoid freezing.
Protection Keep the medicine in its original container, tightly closed, to protect it from light and moisture.
Handling Keep all medicine out of the sight and reach of children.

For disposal, unused or expired Ibuflamar should be discarded through an authorized medicine take-back program if one is available. This is the preferred method endorsed by regulatory agencies. If a take-back option is not accessible, the medicine should be disposed of in household trash only after being mixed with an unappealing substance, such as coffee grounds or dirt, and placed into a sealed bag or container. Do not flush this medicine down the toilet unless specifically instructed by official documentation.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ibuflamar found in:

A-Z Index: